Black Wo(Men) Speak Symposium 2022
Click for an overview of information from the symposium highlighting the need for increased diversity in clinical trials.
All About Phase IV Clinical Trials
Last in our series: Phase IV trials. Learn why these trials are conducted after a treatment has been approved by the FDA.
All About Phase II Clinical Trials
What to know before considering a phase II clinical trial.
All About Phase II Clinical Trials
What to know before considering a phase II clinical trial.
When We Tri(al) Our New Partner!
Learn more about our partnership with When We Tri(al) to improve Black women’s participation in breast cancer clinical trials.
When We Tri(al) Our New Partner!
Learn more about our partnership with When We Tri(al) to improve Black women’s participation in breast cancer clinical trials.
Steps Toward Expanding Eligibility Criteria to Increase Diversity in Clinical Trials
Understand more about the lack of diversity in current clinical trials and steps towards solutions.
Spotlight on the Tigerlily Foundation & Breast Cancer Racial Disparities
Find out more about our newest partner, Tigerlily Foundation, and their new Clinical Trials Initiative.
Modernizing Clinical Trials
Clinical trial modernization is needed. Read about how clinical trial diversity, decentralization, and real-world data is helping to improve the clinical trial process.